ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Santen Pharmaceutical Company (PK)

Santen Pharmaceutical Company (PK) (SNPHY)

9.895
-0.405
(-3.93%)
Closed January 23 4:00PM

Income Statement

Balance Sheet

Cash Flow

Year End March 30 2024 20172018201920202021202220232024
JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
Total Revenue 199.1B224.94B234.46B241.95B265.61B266.81B282.56B302.65B
Operating Income 32.26B45.23B41.55B33.55B12.66B33.87B-4.9B30.98B
Pre Tax Income 31.82B39.26B43.12B32.09B12.42B35.62B-5.8B29.87B
Net Income 23.05B35.26B31.94B21.71B6.65B27.19B-14.98B26.7B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 56.75986.66979.90154.28116.59767.855-39.8673.361
EBIT 32B38.03B45.1B33.54B12.56B34.28B-5.45B30.58B
EBITDA 42.62B56.27B59.51B65.84B80.01B60.89B56.43B66.41B